EntryPoint Capital LLC Takes Position in Grail, Inc. (NASDAQ:GRAL)

EntryPoint Capital LLC purchased a new position in shares of Grail, Inc. (NASDAQ:GRAL) during the fourth quarter, HoldingsChannel reports. The firm purchased 17,153 shares of the company’s stock, valued at approximately $306,000.

Several other institutional investors also recently modified their holdings of GRAL. FNY Investment Advisers LLC bought a new position in Grail during the 4th quarter worth $26,000. Lindbrook Capital LLC bought a new position in shares of Grail during the fourth quarter worth about $28,000. Wellington Shields Capital Management LLC acquired a new position in shares of Grail in the fourth quarter worth approximately $33,000. New York State Common Retirement Fund bought a new stake in Grail in the fourth quarter valued at approximately $59,000. Finally, Wilmington Savings Fund Society FSB acquired a new stake in Grail during the 4th quarter valued at approximately $64,000.

Analysts Set New Price Targets

Separately, Morgan Stanley boosted their price target on shares of Grail from $16.00 to $20.00 and gave the stock an “equal weight” rating in a research report on Tuesday, March 18th.

Grail Stock Up 0.7 %

Shares of GRAL opened at $28.58 on Friday. The firm’s fifty day simple moving average is $33.84 and its two-hundred day simple moving average is $22.26. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99.

Grail (NASDAQ:GRAL) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. On average, equities research analysts predict that Grail, Inc. will post -15.15 earnings per share for the current year.

Insider Transactions at Grail

In related news, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $56,659.20. Following the transaction, the chief financial officer now directly owns 335,170 shares of the company’s stock, valued at $10,457,304. This represents a 0.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Robert P. Ragusa sold 7,625 shares of the firm’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the completion of the sale, the chief executive officer now owns 828,662 shares of the company’s stock, valued at $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,550 shares of company stock valued at $360,436 in the last quarter.

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.